Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000439037

Medchemexpress LLC NUCC-390 | 1060524-97-1 | 98.4% | 395.54 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY11179350MG

Encompass_Preferred

NUCC-390 is a novel and selective small-molecule CXCR4 receptor agonist. It induces internalization of CXCR4 receptors and acts in an opposite way to AMD3100. NUCC-390 has been shown to promote nerve recovery of function after neurodegeneration in vivo.

  • Novel and selective small-molecule CXCR4 receptor agonist.
  • Induces internalization of CXCR4 receptors.
  • Acts in an opposite way to AMD3100.
  • Promotes nerve recovery of function after neurodegeneration in vivo.
  • Boosts axonal growth in cultured cerebellar granule neurons (CGNs) via CXCR4.
  • Contributes to the functional and anatomical recovery of the neuromuscular junction (NMJ) following acute nerve terminal damage in CD-1 mice.

Catalog No. 50-004-39037


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.